Stephen L. Rawlings

Array ( [id] => 8410153 [patent_doc_number] => 08273550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/738883 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35375 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12738883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585444 [patent_doc_number] => 20090104646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Antibodies And Methods For Generating Genetically Altered Antibodies With Enhanced Effector Function' [patent_app_type] => utility [patent_app_number] => 12/251889 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17169 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104646.pdf [firstpage_image] =>[orig_patent_app_number] => 12251889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581884 [patent_doc_number] => 20100291113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Treatment of Proliferative Disorders Using Antibodies to PSMA' [patent_app_type] => utility [patent_app_number] => 12/681341 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291113.pdf [firstpage_image] =>[orig_patent_app_number] => 12681341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992546 [patent_doc_number] => 20110014199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'NOVEL ANTI-IL 13 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/240604 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 26578 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014199.pdf [firstpage_image] =>[orig_patent_app_number] => 12240604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546613 [patent_doc_number] => 20090156490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'PEPTIDES FOR DIAGNOSTIC AND THERAPEUTIC METHODS FOR CELIAC SPRUE' [patent_app_type] => utility [patent_app_number] => 12/238301 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21358 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156490.pdf [firstpage_image] =>[orig_patent_app_number] => 12238301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43415 [patent_doc_number] => 07776607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Mammalian selenoprotein differentially expressed in tumor cells' [patent_app_type] => utility [patent_app_number] => 12/234968 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 19865 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776607.pdf [firstpage_image] =>[orig_patent_app_number] => 12234968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596476 [patent_doc_number] => 07982016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Antigen binding proteins capable of binding thymic stromal lymphopoietin' [patent_app_type] => utility [patent_app_number] => 12/231944 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 34396 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982016.pdf [firstpage_image] =>[orig_patent_app_number] => 12231944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101763 [patent_doc_number] => 20110165255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'MALIGNANT TUMOR HEAT THERAPY KIT COMPRISING ANTI-REGULATORY T CELL ANTIBODY AND MAGNETIC FINE PARTICLES AND HEAT THERAPY METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 13/062033 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3658 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165255.pdf [firstpage_image] =>[orig_patent_app_number] => 13062033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261731 [patent_doc_number] => 20100297004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'HIGH AFFINITY ANTI-PROSTATE STEM CELL ANTIGEN (PSCA) ANTIBODIES FOR CANCER TARGETING AND DETECTION' [patent_app_type] => utility [patent_app_number] => 12/676348 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12011 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297004.pdf [firstpage_image] =>[orig_patent_app_number] => 12676348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264351 [patent_doc_number] => 20090117036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'ANTIBODIES AGAINST GPR64 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/203868 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20600 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117036.pdf [firstpage_image] =>[orig_patent_app_number] => 12203868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13510 [patent_doc_number] => 07803618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Recombinant tumor specific antibody and use thereof' [patent_app_type] => utility [patent_app_number] => 12/201935 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14908 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803618.pdf [firstpage_image] =>[orig_patent_app_number] => 12201935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574901 [patent_doc_number] => 20090142262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 12/199482 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11289 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142262.pdf [firstpage_image] =>[orig_patent_app_number] => 12199482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838198 [patent_doc_number] => 08865875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions' [patent_app_type] => utility [patent_app_number] => 12/674503 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 28623 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12674503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452145 [patent_doc_number] => 20090068182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD9' [patent_app_type] => utility [patent_app_number] => 12/228682 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 32650 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068182.pdf [firstpage_image] =>[orig_patent_app_number] => 12228682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038436 [patent_doc_number] => 20110091485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'MODULATION OF CELL JUNCTIONS' [patent_app_type] => utility [patent_app_number] => 12/672290 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19930 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091485.pdf [firstpage_image] =>[orig_patent_app_number] => 12672290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343486 [patent_doc_number] => 20100330090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'ANTAGONIST ANTIBODIES OF PROTEASE ACTIVATED RECEPTOR-1 (PAR1)' [patent_app_type] => utility [patent_app_number] => 12/669467 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17854 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330090.pdf [firstpage_image] =>[orig_patent_app_number] => 12669467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807561 [patent_doc_number] => 08445211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'I-Plastin assay method for the in vitro diagnosis of colorectal cancer' [patent_app_type] => utility [patent_app_number] => 12/452042 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 22851 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581872 [patent_doc_number] => 20100291112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Recombinant, Single-Chain, Trivalent Tri-Specific or Bi-Specific Antibody Derivatives' [patent_app_type] => utility [patent_app_number] => 12/668277 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22939 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291112.pdf [firstpage_image] =>[orig_patent_app_number] => 12668277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13160 [patent_doc_number] => 07807373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer' [patent_app_type] => utility [patent_app_number] => 12/166723 [patent_app_country] => US [patent_app_date] => 2008-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11932 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807373.pdf [firstpage_image] =>[orig_patent_app_number] => 12166723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238679 [patent_doc_number] => 08603467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/664696 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 35138 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12664696 [rel_patent_id] =>[rel_patent_doc_number] =>)